1 not yet recruiting, 1 unknown. 2 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Not yet recruiting 1, Unknown 1 |
| Phase 3 | 1 | Not yet recruiting 1 |
Follow PAIS: new trials by email Literature Review of PAIS trials Research Report on PAIS
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Intranasal Stem Cells to Treat Perinatal Brain Injury to Combat Cerebral Palsy MSC, marrow, Placebo - Perinatal Arterial Ischemic Stroke, Perinatal Asphyxia | Phase 2 / Phase 3 | Not yet recruiting | UMC Utrecht | 162 | 2027-04-01 | 2026-09-21 |
| Darbepoetin for Ischemic Neonatal Stroke to Augment Regeneration Darbepoetin Alfa, Saline - PAIS, Neonatal Stroke | Phase 2 | Unknown | UMC Utrecht | 80 | 2017-07-01 | 2023-12-07 |
Brain Diseases (1) · Brain Ischemia (1) · Cardiovascular Diseases (1) · Central Nervous System Diseases (1) · Cerebrovascular Disorders (1) · Hypoxia (1) · Hypoxia, Brain (1) · Nervous System Diseases (1) · Pathological Conditions, Signs and Symptoms (1) · Signs and Symptoms (1) · Signs and Symptoms, Respiratory (1) · Vascular Diseases (1)
Darbepoetin alfa (1) · Sodium Chloride (1)
UMC Utrecht (2)
Netherlands (1)
2025 (1)